Pathophysiology of pulmonary function anomalies in COVID-19 survivors
Coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the predisposing and protecting factors have not been fully elucidated. COVID-19 primarily impacts the respiratory system, and can result in mild illness o...
Guardado en:
Autores principales: | Pierantonio Laveneziana, Lucile Sesé, Thomas Gille |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04d3c8bcbbe445dfbce6d0a55cb83b81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: A. Marques
Publicado: (2021) -
Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Sotirios Kakavas, et al.
Publicado: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021) -
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Massimo Girardis, et al.
Publicado: (2021) -
Periodontal Diseases: Major Exacerbators of Pulmonary Diseases?
por: Bakey Kouanda, et al.
Publicado: (2021)